Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × SCLC × atezolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 23 Colorectal Neoplasms 14 Neoplasms 12 Melanoma 11 Carcinoma, Renal Cell 10 Neoplasm Metastasis 8 Carcinoma, Hepatocellular 8 Head and Neck Neoplasms 7 Urinary Bladder Neoplasms 6 Triple Negative Breast Neoplasms 6 Stomach Neoplasms 6 Solid Tumors 6 Small Cell Lung Carcinoma 6 Lung Neoplasms 6 Carcinoma, Transitional Cell 6 Ovarian Neoplasms 5 Lymphoma 5 Squamous Cell Carcinoma of Head and Neck 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Solid Tumor 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Kidney Neoplasms 3 Endometrial Neoplasms 3 Advanced Solid Tumors 3 Urologic Neoplasms 2 Solid Cancers 2 Recurrence 2 Multiple Myeloma 2

Interventions

Carboplatin 2 sintilimab 1 atezolizumab 1 Etoposide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06179069 2025-08-15

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Zai Lab (Hong Kong), Ltd.

Phase 1 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡